First Patients in U.S. Treated with Distalmotion’s Dexter Surgical Robot in the Outpatient Setting Lausanne, Switzerland, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Less than 30 days after receiving FDA De Novo marketing authorization, Distalmotion’s Dexter Surgical Robot has successfully treated the...

FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot Lausanne, Switzerland, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult...

Industry Leader Greg Roche Joins Distalmotion as CEO Lausanne, Switzerland, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Distalmotion, a pioneer in novel, on-demand robotics, has hired medical device industry leader, Greg Roche, as CEO. Subject to shareholder...

Industry Leader Greg Roche Joins Distalmotion as CEO Lausanne, Switzerland, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Distalmotion, a pioneer in novel, on-demand robotics, has hired medical device industry leader, Greg Roche, as CEO. Subject to shareholder...